Processa Pharmaceuticals, Inc. (PCSA) stock
PCSANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.73+0.01 (+0.58%)
Close on Nov 17, 2026Market cap $4.83MP/E –Yield –
Processa Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Processa Pharmaceuticals's price to book ratio was 2.3× on Jul 31, 2026, against 0.3× a year earlier. Over the last 5 years it ranged from 0.3× to 4.6×, with a median of 1.1×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jul 31, 2026 | 2.3× | +1.2 |
| 2025 | Dec 31, 2025 | 1.0× | +0.3 |
| 2024 | Dec 31, 2024 | 0.8× | −0.4 |
| 2023 | Dec 29, 2023 | 1.1× | +0.1 |
| 2022 | Dec 30, 2022 | 1.0× | −1.8 |
| 2021 | Dec 31, 2021 | 2.8× | −4.1 |
| 2020 | Dec 31, 2020 | 6.9× | −4.5 |
| 2019 | Dec 31, 2019 | 11.4× | −1.9 |
| 2018 | Dec 31, 2018 | 13.3× | −279.8 |
| 2015 | Jul 31, 2015 | 293.0× | −203.3 |
| 2014 | Oct 31, 2014 | 496.4× | – |
See a number that looks wrong?